Prescryptive and Ilant Health today announced a collaboration to help employers access transparent GLP-1 pricing alongside expert, outcomes-driven clinical care. The collaboration runs on Prescryptive ...
Best semaglutide for weight loss in 2026 explained. Explore FDA-approved options, GLP-1 programs, safety, access pathways, ...
Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics market HYFT®-driven discovery supports ...
NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Berry Street, an AI-powered nutrition therapy platform, today announced the launch of its GLP-1 Nutrition Pathway Program, a comprehensive, structured ...
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
Everyday Health on MSN
Can GLP-1 drugs for obesity and diabetes also treat other diseases?
Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...
“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...
New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
MedPage Today on MSN
GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...
Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...
Flow Space on MSN
What to know about transitioning off a GLP-1
Stopping a GLP-1 suddenly, especially after long-term use, may lead to a rapid return of false hunger signals, distracting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback